Zurich Cantonal Bank’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-9,723
Closed -$11K 2959
2022
Q1
$11K Hold
9,723
﹤0.01% 2708
2021
Q4
$24K Hold
9,723
﹤0.01% 2848
2021
Q3
$50K Hold
9,723
﹤0.01% 2616
2021
Q2
$81K Hold
9,723
﹤0.01% 2305
2021
Q1
$85K Hold
9,723
﹤0.01% 2218
2020
Q4
$106K Hold
9,723
﹤0.01% 2189
2020
Q3
$116K Hold
9,723
﹤0.01% 1917
2020
Q2
$156K Buy
9,723
+3,045
+46% +$53.2K ﹤0.01% 1689
2020
Q1
$104K Buy
6,678
+1,114
+20% +$23.9K ﹤0.01% 1592
2019
Q4
$137K Hold
5,564
﹤0.01% 1539
2019
Q3
$57K Buy
5,564
+1,262
+29% +$15.9K ﹤0.01% 1952
2019
Q2
$54K Hold
4,302
﹤0.01% 2014
2019
Q1
$53K Sell
4,302
-1,132
-21% -$12.7K ﹤0.01% 1965
2018
Q4
$33K Hold
5,434
﹤0.01% 2262
2018
Q3
$58K Hold
5,434
﹤0.01% 2074
2018
Q2
$74K Buy
5,434
+4,446
+450% +$69.2K ﹤0.01% 1856
2018
Q1
$18K Hold
988
﹤0.01% 2432
2017
Q4
$12K Hold
988
﹤0.01% 2481
2017
Q3
$19K Hold
988
﹤0.01% 2279
2017
Q2
$15K Buy
988
+566
+134% +$8.56K ﹤0.01% 2342
2017
Q1
$7K Hold
422
﹤0.01% 2538
2016
Q4
$5K Hold
422
﹤0.01% 2530
2016
Q3
$4K Hold
422
﹤0.01% 2534
2016
Q2
$4K Hold
422
﹤0.01% 2522
2016
Q1
$5K Hold
422
﹤0.01% 2508
2015
Q4
$7K Hold
422
﹤0.01% 2487
2015
Q3
$5K Buy
+422
New +$8.52K ﹤0.01% 2404

Other funds holding EPZM

Zurich Cantonal Bank's EPZM Position: Q2 2022 in Review

Zurich Cantonal Bank sold out of Epizyme, Inc (EPZM) in Q2 2022, closing a stake of 9,723 shares — an estimated $11K sold.

Zurich Cantonal Bank first reported a position in EPZM in Q3 2015 and held it in 27 quarters. The position peaked at $156K in Q2 2020. 93 funds tracked by Wall St. Rank hold EPZM as of Q2 2022.

  • Zurich Cantonal Bank reported no remaining Epizyme, Inc position as of Q2 2022 after selling out during the quarter.
  • Zurich Cantonal Bank sold 9,723 Epizyme, Inc shares in Q2 2022, an estimated $11K.
  • Zurich Cantonal Bank first reported a position in Epizyme, Inc in Q3 2015 and held it in 27 quarters.
  • Zurich Cantonal Bank's Epizyme, Inc position peaked at $156K in Q2 2020.
  • 93 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2022.

Based on Zurich Cantonal Bank's 13F filing for Q2 2022, filed 9 Aug 2022.